GR3026519T3 - New method of treating depression - Google Patents

New method of treating depression

Info

Publication number: GR3026519T3
Authority: GR; Greece
Prior art keywords: new method; treating depression; depression; treating; compounds
Prior art date: 1990-10-12

Application number

GR980400703T

Other languages

Greek (el)

English (en)

Inventor

Jan David Wallace

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-12

Filing date

1998-04-03

Publication date

1998-07-31

1998-04-03 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1998-07-31 Publication of GR3026519T3 publication Critical patent/GR3026519T3/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

GR980400703T 1990-10-12 1998-04-03 New method of treating depression GR3026519T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/596,270 US5025035A (en)	1990-10-12	1990-10-12	Method of treating depression
PCT/US1991/007330 WO1992006686A1 (fr)	1990-10-12	1991-10-02	Nouveau procede de traitement de la depression

Publications (1)

Publication Number	Publication Date
GR3026519T3 true GR3026519T3 (en)	1998-07-31

Family

ID=24386662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR980400703T GR3026519T3 (en)	1990-10-12	1998-04-03	New method of treating depression

Country Status (11)

Country	Link
US (1)	US5025035A (fr)
EP (1)	EP0552240B1 (fr)
JP (1)	JP3192141B2 (fr)
AT (1)	ATE164065T1 (fr)
CA (1)	CA2092416A1 (fr)
DE (1)	DE69129115T2 (fr)
DK (1)	DK0552240T3 (fr)
ES (1)	ES2116298T3 (fr)
GR (1)	GR3026519T3 (fr)
MX (1)	MX9101526A (fr)
WO (1)	WO1992006686A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5025035A (en) *	1990-10-12	1991-06-18	Warner-Lambert Company	Method of treating depression
US5510381A (en) *	1995-05-15	1996-04-23	Warner-Lambert Company	Method of treatment of mania and bipolar disorder
KR100512506B1 (ko) *	1996-03-14	2005-12-21	워너-램버트 캄파니 엘엘씨	제약제제로서신규한치환시클릭아미노산
US6372792B1 (en)	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
AU714980B2 (en)	1996-07-24	2000-01-13	Warner-Lambert Company Llc	Isobutylgaba and its derivatives for the treatment of pain
US6194459B1 (en)	1997-08-19	2001-02-27	Warner-Lambert Company	Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
WO1999018063A2 (fr)	1997-10-07	1999-04-15	Warner-Lambert Company	Procede de preparation d'un compose anticonvulsif, aminoacide et cyclique
HUP0004310A3 (en) *	1997-10-27	2001-11-28	Warner Lambert Co	Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
BR9910494B1 (pt) *	1998-05-15	2011-11-01		composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo.
PL204921B1 (pl)	1998-05-15	2010-02-26	Warner Lambert Co	Stabilizowana kompozycja farmaceutyczna zawierająca 4-amino-3-podstawioną pochodną kwasu butanowego i α-aminokwas oraz sposób jej wytwarzania
US6992109B1 (en) *	1999-04-08	2006-01-31	Segal Catherine A	Method for the treatment of incontinence
CA2370030C (fr) *	1999-04-09	2007-08-14	Euro-Celtique S.A.	Composition de blocage du canal sodique et leur utilisation
HUP0200733A3 (en) *	1999-04-09	2003-04-28	Warner Lambert Co	Combinations of gaba analogs and tricyclic compounds to treat depression
AP2002002501A0 (en) *	1999-10-07	2002-06-30	Warner Lambert Co	Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
WO2001097612A1 (fr)	2000-06-16	2001-12-27	Teva Pharmaceutical Industries Ltd.	Gabapentine stable contenant plus de 20 ppm d'ions chlore
JP4350508B2 (ja)	2001-09-03	2009-10-21	ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー	ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
ITMI20012750A1 (it)	2001-12-21	2003-06-21	Procos Spa	Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20030119908A1 (en) *	2001-12-21	2003-06-26	Zambon Group S.P.A.	Stable gabapentin compositions
US20050181071A1 (en) *	2004-02-18	2005-08-18	Binder Michael R.	Method for the treatment of clinical depression
SI1809271T1 (sl) *	2004-09-10	2010-10-29	Newron Pharm Spa	Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
IN2012MN02923A (fr)	2010-06-01	2015-06-05	Rubicon Res Private Ltd
WO2015144825A1 (fr)	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Solution pharmaceutique liquide orale de gabapentine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
US5084479A (en) *	1990-01-02	1992-01-28	Warner-Lambert Company	Novel methods for treating neurodegenerative diseases
US5025035A (en) *	1990-10-12	1991-06-18	Warner-Lambert Company	Method of treating depression

1990
- 1990-10-12 US US07/596,270 patent/US5025035A/en not_active Expired - Lifetime
1991
- 1991-10-02 DE DE69129115T patent/DE69129115T2/de not_active Expired - Fee Related
- 1991-10-02 JP JP51703391A patent/JP3192141B2/ja not_active Expired - Fee Related
- 1991-10-02 CA CA002092416A patent/CA2092416A1/fr not_active Abandoned
- 1991-10-02 AT AT91918381T patent/ATE164065T1/de not_active IP Right Cessation
- 1991-10-02 EP EP91918381A patent/EP0552240B1/fr not_active Expired - Lifetime
- 1991-10-02 WO PCT/US1991/007330 patent/WO1992006686A1/fr not_active Ceased
- 1991-10-02 ES ES91918381T patent/ES2116298T3/es not_active Expired - Lifetime
- 1991-10-02 DK DK91918381T patent/DK0552240T3/da active
- 1991-10-10 MX MX9101526A patent/MX9101526A/es unknown
1998
- 1998-04-03 GR GR980400703T patent/GR3026519T3/el unknown

Also Published As

Publication number	Publication date
ATE164065T1 (de)	1998-04-15
WO1992006686A1 (fr)	1992-04-30
ES2116298T3 (es)	1998-07-16
DK0552240T3 (da)	1998-11-23
CA2092416A1 (fr)	1992-04-13
JP3192141B2 (ja)	2001-07-23
MX9101526A (es)	1992-06-05
EP0552240B1 (fr)	1998-03-18
US5025035A (en)	1991-06-18
DE69129115D1 (de)	1998-04-23
EP0552240A4 (en)	1993-09-01
JPH06502148A (ja)	1994-03-10
DE69129115T2 (de)	1998-07-16
EP0552240A1 (fr)	1993-07-28

Similar Documents

Publication	Publication Date	Title
GR3026519T3 (en)	1998-07-31	New method of treating depression
DE69432704D1 (de)	2003-06-26	Verfahren zur Herstellung von humanen Relaxin
IE901673L (en)	1990-11-09	Enzymatic removal of a protein amino-terminal sequence
ATE150319T1 (de)	1997-04-15	Behandlung von asthma
HUP9900935A2 (hu)	1999-07-28	Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
HU9501288D0 (en)	1995-06-28	Recombinant method and host for manufacture of xylitol
DK356785A (da)	1986-02-09	Fremgangsmaade til inhibering af carbamylering ved behandling af peptider
ATE111439T1 (de)	1994-09-15	Verfahren zur herstellung von levodopa.
HUT70218A (en)	1995-09-28	Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines
ATE218131T1 (de)	2002-06-15	Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
DE69131657D1 (de)	1999-11-04	Verfahren zur industriellen Herstellung von 4-Chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-Benzamid
MY115046A (en)	2003-03-31	Medicinal composition for diabetes
DE3667960D1 (de)	1990-02-08	Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
HUT36783A (en)	1985-10-28	Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
ATE161269T1 (de)	1998-01-15	Verfahren zur herstellung von peptiden und neue zwischenverbindungen dazu
NO903338D0 (no)	1990-07-27	Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
DE69009394D1 (de)	1994-07-07	Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
EP0490383A3 (en)	1993-06-30	Peptides of the hiv-gag protein, their preparation and use
NZ228023A (en)	1991-10-25	24(r)-scymnol; preparatory processes and pharmaceutical compositions
ATE107165T1 (de)	1994-07-15	Verwendung von macrolactonen als antiallergica.
ES2166545T3 (es)	2002-04-16	Procedimiento de preparacion de un aminoacido activado.
ATE93832T1 (de)	1993-09-15	Verfahren zur herstellung von 4,6-dimethyl-7hydroxynonan-3-on.
DE68916805D1 (de)	1994-08-18	Verfahren zur herstellung von tocopherolen.
DE59405085D1 (de)	1998-02-26	Verfahren zur Herstellung von Tetrachlor-1,4-benzochinon
DE69007028D1 (de)	1994-04-07	Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.